Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Surabhi B. Vora"'
Autor:
Warren Szewczyk, Annette L. Fitzpatrick, Herve Fossou, Nicole L. Gentile, Nona Sotoodehnia, Surabhi B. Vora, T. Eoin West, Jeanne Bertolli, Jennifer R. Cope, Jin-Mann S. Lin, Elizabeth R. Unger, Quan M. Vu
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Recovery from SARS CoV-2 infection is expected within 3 months. Long COVID occurs after SARS-CoV-2 when symptoms are present for more than 3 months that are continuous, relapsing and remitting, or progressive. Better understanding
Externí odkaz:
https://doaj.org/article/e2410f2f32fb467a8917026d2e78a65c
Autor:
Stephanie E. McLaughlin, M.D., M.P.H., Surabhi B. Vora, M.D., E. Chandler Church, M.D., M.Sc., Christopher Spitters, M.D., Angela Thyer, M.D., Sylvia LaCourse, M.D., Christopher N. Herndon, M.D.
Publikováno v:
F&S Reports, Vol 3, Iss 3, Pp 285-291 (2022)
Objective: To report 2 cases of adverse pregnancy outcomes due to delayed diagnosis of urogenital tuberculosis and propose a screening algorithm for patients from tuberculosis-endemic countries. Design: Case report. Setting: Academic medical center.
Externí odkaz:
https://doaj.org/article/cba0bd7503eb40218369b91c962fd0c6
Autor:
Gilad Sherman, Gabriella S Lamb, Tanvi S Sharma, Elizabeth C Lloyd, Jerod Nagel, Nada N Dandam, Carlos R Oliveira, Hassan S Sheikha, Brenda I Anosike, Philip Lee, Surabhi B Vora, Karisma Patel, Paul K Sue, Beenish Rubbab, April M Yarbrough, Lakshmi Ganapathi, Mari M Nakamura
Publikováno v:
Journal of the Pediatric Infectious Diseases Society. 12:152-155
Monoclonal antibodies for COVID-19 are authorized in high-risk patients aged ≥12 years, but evidence in pediatric patients is limited. In our cohort of 142 patients treated at seven pediatric hospitals between 12/1/20 and 7/31/21, 9% developed adve
Autor:
Surabhi B. Vora, Janet A. Englund, Indi Trehan, Alpana Waghmare, Ada Kong, Amanda Adler, Danielle M. Zerr
Publikováno v:
The Pediatric infectious disease journal. 42(1)
Multiple antiviral and monoclonal antibody therapies are now available for mild-moderate COVID-19 in high-risk patients ≥12 years of age. However, data for the use of these agents in children is limited. We reviewed 94 pediatric patients for whom e
Autor:
Surabhi B. Vora, Janet A. Englund, Indi Trehan, Alpana Waghmare, Ada Kong, Amanda Adler, Danielle M. Zerr
The recent surge of SARS-CoV-2 Omicron variant (B.1.1.529) coincided with new treatment options for mild-to-moderate Covid-19 in high-risk adolescents and adults. In this report we describe patient characteristics, treatment-related process measures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ebced91b3d0d296f7546a9d890654bb
https://doi.org/10.1101/2022.03.16.22272511
https://doi.org/10.1101/2022.03.16.22272511
Autor:
Kathleen Chiotos, Molly Hayes, David W Kimberlin, Sarah B Jones, Scott H James, Swetha G Pinninti, April Yarbrough, Mark J Abzug, Christine E MacBrayne, Vijaya L Soma, Daniel E Dulek, Surabhi B Vora, Alpana Waghmare, Joshua Wolf, Rosemary Olivero, Steven Grapentine, Rachel L Wattier, Laura Bio, Shane J Cross, Nicholas O Dillman, Kevin J Downes, Carlos R Oliveira, Kathryn Timberlake, Jennifer Young, Rachel C Orscheln, Pranita D Tamma, Hayden T Schwenk, Philip Zachariah, Margaret L Aldrich, David L Goldman, Helen E Groves, Nipunie S Rajapakse, Gabriella S Lamb, Alison C Tribble, Adam L Hersh, Emily A Thorell, Mark R Denison, Adam J Ratner, Jason G Newland, Mari M Nakamura
Publikováno v:
Journal of the Pediatric Infectious Diseases Society
Background Although coronavirus disease 2019 (COVID-19) is a mild infection in most children, a small proportion develop severe or critical illness. Data describing agents with potential antiviral activity continue to expand such that updated guidanc
Autor:
Jeffery J. Auletta, Julianne E. Burns, Kengo Inagaki, Felice C. Adler-Shohet, Sharon Nachman, Andi L. Shane, Beatriz Larru Martinez, Ibukunoluwa C. Akinboyo, Frank Zhu, Vanessa Raabe, Karen L. Kotloff, Alice I Sato, Roberto Parulan Santos, Charles R. Woods, Claudia M Espinosa, Coleen K. Cunningham, Surabhi B Vora, Taito Kitano, Mundeep K Kainth, Jonathan D. Crews, Lisa Saiman, Carol M. Kao, Abdulsalam O Alsulami, Samuel R. Dominguez
Publikováno v:
Journal of the Pediatric Infectious Diseases Society
Understanding the role that children play in the clinical burden and propagation of severe acute respiratory syndrome coronavirus 2, responsible for coronavirus disease 2019 (COVID-19) infections, is emerging. While the severe manifestations and acut
Autor:
Emily A. Thorell, Kevin J. Downes, Rachel L. Wattier, Nicholas O Dillman, Sarah B. Jones, Mark R. Denison, Pranita D. Tamma, Margaret L. Aldrich, Alpana Waghmare, April Yarbrough, Kathryn Timberlake, Mark J. Abzug, Helen E. Groves, David L. Goldman, Steven P. Grapentine, David W. Kimberlin, Rosemary Olivero, Daniel E. Dulek, Laura Bio, Mari M. Nakamura, Vijaya L. Soma, Joshua Wolf, Christine E. MacBrayne, Shane J Cross, Jason G. Newland, Jennifer L. Young, Alison C Tribble, Rachel C Orscheln, Hayden T. Schwenk, Surabhi B Vora, Philip Zachariah, Swetha G. Pinninti, Scott H. James, Adam L. Hersh, Molly Hayes, Adam J. Ratner, Gabriella S Lamb, Kathleen Chiotos
Publikováno v:
Journal of the Pediatric Infectious Diseases Society
BackgroundAlthough coronavirus disease 2019 (COVID-19) is mild in nearly all children, a small proportion of pediatric patients develop severe or critical illness. Guidance is therefore needed regarding use of agents with potential activity against s
Publikováno v:
J Pediatric Infect Dis Soc
Background Over the past several decades, there have been advances in diagnosis and treatment of neonatal herpes simplex virus (HSV) disease. There has been no recent comprehensive evaluation of the impact of these advances on the management and outc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce49d8becd4f0101e15a86cf636a467f
https://europepmc.org/articles/PMC8946680/
https://europepmc.org/articles/PMC8946680/
Autor:
Stephanie E. McLaughlin, Surabhi B. Vora, E. Chandler Church, Christopher Spitters, Angela Thyer, Sylvia LaCourse, Christopher N. Herndon
Publikováno v:
FS reports. 3(3)
To report 2 cases of adverse pregnancy outcomes due to delayed diagnosis of urogenital tuberculosis and propose a screening algorithm for patients from tuberculosis-endemic countries.Case report.Academic medical center.Two patients with delayed diagn